We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

AI:EURONEXT PARISAir Liquide SA Analysis

Data as of 2026-07-02 - not real-time

$9.06

Latest Price

8/10Risk

Risk Level: High

Executive Summary

The stock is trading near its recent support level while the short‑term moving average remains above the longer‑term average, suggesting a tenuous neutral stance. Momentum indicators show the RSI hovering in the lower‑mid range, implying limited buying pressure. The MACD histogram is negative and the line sits below its signal, reinforcing a bearish short‑term bias. Daily volume has been trending lower, which may diminish price resilience on downside moves. Market sentiment is currently dominated by extreme greed, a condition that can exacerbate price swings in a volatile environment. On the fundamentals side, the company reports negative earnings per share and operating losses, indicating profitability challenges.
Gross margins are modest, while operating cash flow remains negative, highlighting ongoing cash generation concerns. The balance sheet shows a modest cash reserve that slightly exceeds total debt, but the debt‑to‑equity ratio is elevated. Valuation multiples are high relative to sales and book value, and the forward price‑to‑earnings projection is negative, pointing to an overvalued pricing scenario. The firm operates in a high‑beta, high‑volatility technology segment, which amplifies systematic risk. Regulatory scrutiny of artificial intelligence applications is increasing, adding a layer of uncertainty to the business outlook. Given the blend of weak earnings, elevated risk metrics, and a market environment marked by speculative enthusiasm, the stock warrants a cautious approach.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • bearish MACD signal
  • declining volume
  • support near current price

Medium Term

1–3 years
Neutral
Model confidence: 4/10

Key Factors

  • ongoing operating losses
  • high volatility
  • uncertain regulatory environment

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • strategic cloud partnerships
  • potential AI adoption growth
  • cash cushion exceeds debt

Key Metrics & Analysis

Financial Health

Revenue Growth-52.50%
Profit Margin-187.95%
P/E Ratio-20.1
ROE-63.05%
ROA-33.09%
Debt/Equity8.98
P/B Ratio2.1
Op. Cash Flow$-190228000
Free Cash Flow$-26476750
Industry P/E36.0

Technical Analysis

TrendNeutral
RSI40.9
Support$8.50
Resistance$11.36
MA 20$10.04
MA 50$9.67
MA 200$12.39
MACDBearish
VolumeDecreasing
Fear & Greed Index92.59

Valuation

Target Price$8.82
Upside/Downside-2.67%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta2.39
Volatility60.99%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.